XML 24 R17.htm IDEA: XBRL DOCUMENT
v3.25.3

Leases | 9 Months Ended
--- | ---
Sep. 30, 2025
Leases [Abstract] |
Leases | 7. Leases In October 2019, the Company entered into a noncancelable facility lease agreement (the “2019 Lease”) for 34,522 square feet of research and development and office space in Watertown, Massachusetts. The term of the 2019 Lease is 120 months and expires on March 31, 2030. The 2019 Lease has an option to be extended for an additional five years. The lease is not reasonably certain to be extended and as such the additional term is not included in the measurement of the lease. The 2019 Lease includes a rent escalation clause, and rent expense is being recorded on a straight-line basis. In accordance with the lease agreement, the Company is required to maintain a security deposit and provided a letter of credit to the landlord, which is recorded in restricted cash as of September 30, 2025 and December 31, 2024. The letter of credit totaled $1.3 million and $1.3 million as of September 30, 2025 and December 31, 2024, respectively. In December 2021, the Company entered into a noncancelable lease (the “2021 Lease”) for 100,624 square feet of office and laboratory space in Watertown, Massachusetts, which the Company began occupying in February 2024. The 2021 Lease is subject to base rent of $0.8 million per month beginning two months after the commencement date, plus the Company’s ratable share of taxes, maintenance and other operating expenses. Base rent is subject to a 3% annual increase over the lease term of approximately 134 months following the commencement date. The Company also has two consecutive options to extend the term of the lease for five years each at then-market rates. The 2021 Lease also includes a tenant improvement allowance of approximately $20.1 million. In connection with the signing of the 2021 Lease, the Company issued a letter of credit for $4.5 million which is classified as restricted cash as of September 30, 2025 and December 31, 2024. The 2021 Lease required the landlord to build-out the base building prior to the construction of the Company’s premises. The Company concluded the accounting commencement date occurred when the landlord completed the build-out of the base building and control passed to the Company, which occurred in early January 2023. The Company assessed the classification of the 2021 Lease at the accounting commencement date and concluded the lease should be accounted for as an operating lease. The Company recorded an operating lease liability of $48.9 million, measured as the present value of the remaining lease payments discounted using the incremental borrowing rate as of the accounting commencement date. The Company recorded an operating lease right-of-use asset of $48.9 million, measured as the present value of the remaining lease payments, net of the tenant incentives. The Company concluded the improvements paid for by the landlord in connection with the tenant improvement allowance represent lessee assets and therefore recorded $20.1 million of leasehold improvements in property and equipment. The Company recorded an additional $17.9 million of leasehold improvements in excess of the tenant improvement allowance, all of which were placed in service in 2024. Upon occupancy of the 2021 Lease facility in February of 2024, the Company exited the 2019 Lease facility and is actively looking to sublease the entire facility for the remaining noncancellable lease term through March 31, 2030. These actions resulted in an impairment charge of $4.9 million in the three months ended March 31, 2024. During the three months ended September 30, 2025, given the continued vacancy of the space and further declining market conditions related to office and lab space, the Company revised its estimate of the fair value of the asset group associated with the 2021 Lease facility. This resulted in an incremental impairment charge of $3.9 million. The Company will continue to evaluate the potential recovery of the asset group under sublease scenarios, and thus it is possible that further additional impairments could be identified in future periods, and such amounts could be material. The impairment charges reduce the carrying value of the associated ROU asset, leasehold improvements and certain furniture and fixture assets that remained in the facility to their estimated fair values. In both periods, the fair values were estimated using a discounted cash flows approach based on forecasted future cash flows expected to be derived from the property based on estimated sublease market rent, which are considered a level 3 input in the fair value hierarchy, and other key assumptions such as future sublease market conditions and the discount rate. The Company’s finance lease obligations consist of certain property and equipment financed through finance leases. The components of the lease costs for the three and nine months ended September 30, 2025 and 2024, were as follows (in thousands):
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Operating lease costs |  | $ | 2,452 |  |  | $ | 2,493 |  |  | $ | 7,388 |  |  | $ | 7,484 |
Finance lease costs: |  |  |  |  |  |  |  |  |  |  |  |
Amortization of right-to-use assets, finance leases |  |  | 440 |  |  |  | 314 |  |  |  | 1,186 |  |  |  | 1,109 |
Interest expense for finance lease liabilities |  |  | 85 |  |  |  | 52 |  |  |  | 237 |  |  |  | 137 |
Variable lease costs |  |  | 1,462 |  |  |  | 1,421 |  |  |  | 4,505 |  |  |  | 4,011 |
Total lease costs |  | $ | 4,439 |  |  | $ | 4,280 |  |  | $ | 13,316 |  |  | $ | 12,741 |
Supplemental cash flow information relating to the Company’s leases for the nine months ended September 30, 2025 and 2024, were as follows (in thousands):
|  | Nine Months Ended September 30, |
|  | 2025 |  |  | 2024 |
Cash paid for amounts included in the measurement of lease liabilities: |  |  |  |  |  |
Operating cash flows used in operating leases |  | $ | 9,031 |  |  | $ | 6,570 |
Operating cash flows used in finance leases |  | $ | 1,077 |  |  | $ | 1,010 |
Financing cash flows used in finance leases |  | $ | 237 |  |  | $ | 137 |
Weighted average remaining lease terms and discount rates as of September 30, 2025 and 2024 were as follows:
|  | Nine Months Ended September 30, |
|  | 2025 |  |  | 2024 |
Remaining lease term: |  |  |  |  |  |
Operating lease |  | 8.84 years |  |  | 9.78 years |
Finance lease |  | 2.35 years |  |  | 2.57 years |
Discount Rate: |  |  |  |  |  |
Operating lease |  |  | 8.70 | % |  |  | 8.72 | %
Finance lease |  |  | 8.78 | % |  |  | 8.58 | %
The undiscounted future lease payments for operating and finance leases as of September 30, 2025, were as follows (in thousands):
Fiscal Year |  | Operating Leases |  |  | Finance Leases |
2025 (fourth quarter) |  | $ | 3,042 |  |  | $ | 491 |
2026 |  |  | 12,436 |  |  |  | 1,885 |
2027 |  |  | 12,809 |  |  |  | 1,180 |
2028 |  |  | 13,193 |  |  |  | 449 |
2029 |  |  | 13,589 |  |  |  | 72 |
Thereafter |  |  | 60,835 |  |  |  | — |
Total minimum lease payments |  | $ | 115,904 |  |  | $ | 4,077 |
Less amounts representing interest or imputed interest |  |  | (35,601 | ) |  |  | (383 | )
Present value of lease liabilities |  | $ | 80,303 |  |  | $ | 3,694 |

X
- Definition Lessee operating and finance leases. + References No definition available. + Details
Name: | kymr_LesseeOperatingAndFinanceLeasesTextBlock
Namespace Prefix: | kymr_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_LeasesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration